title: The controversy regarding contrast echocardiography and how it affects patients with the cardiometabolic syndrome.
authors.affiliation: Department of Medicine, Division of Cardiology, Washington University School of Medicine, St Louis, MO 63110, USA.
authors.forename: Daniel L
authors.initials: DL
authors.lastname: Wagner
authors.forename: Julio E
authors.initials: JE
authors.lastname: Pérez
authors.forename: Linda R
authors.initials: LR
authors.lastname: Peterson
authors.forename: Ravi
authors.initials: R
authors.lastname: Rasalingam
mesh_terms: D003287:Contrast Media / Q000008:administration & dosage*; D003327:Coronary Disease / Q000150:complications / Q000000981:diagnostic imaging* / Q000503:physiopathology; D003937:Diagnosis, Differential; D004452:Echocardiography / Q000379:methods*; D005466:Fluorocarbons; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000000981:diagnostic imaging* / Q000503:physiopathology; D007275:Injections, Intravenous; D008297:Male; D024821:Metabolic Syndrome / Q000150:complications* / Q000000981:diagnostic imaging; D045423:Microbubbles; D008875:Middle Aged; D015203:Reproducibility of Results; D018487:Ventricular Dysfunction, Left / Q000150:complications / Q000000981:diagnostic imaging* / Q000503:physiopathology
chemical_list: D003287:Contrast Media; D005466:Fluorocarbons